-
*67466202020100101*
LIFE AND ACCIDENT AND HEALTH COMPANIES/FRATERNAL BENEFIT
SOCIETIES - ASSOCIATION EDITION
QUARTERLY STATEMENT AS OF MARCH 31, 2020
OF THE CONDITION AND AFFAIRS OF THE
PACIFIC LIFE INSURANCE COMPANY NAIC Group Code 0709 0709 NAIC
Company Code 67466 Employer's ID Number 95-1079000
(Current) (Prior)
Organized under the Laws of NEBRASKA , State of Domicile or Port
of Entry NEBRASKA
Country of Domicile UNITED STATES OF AMERICA Licensed as
business type: LIFE, ACCIDENT & HEALTH
Incorporated/Organized 01/02/1868 Commenced Business
05/01/1868
Statutory Home Office 6750 MERCY ROAD , OMAHA , NE, US 68106
(Street and Number) (City or Town, State, Country and Zip
Code)
Main Administrative Office 700 NEWPORT CENTER DRIVE (Street and
Number)
NEWPORT BEACH , CA, US 92660 , 949-219-3011 (City or Town,
State, Country and Zip Code) (Area Code) (Telephone Number)
Mail Address 700 NEWPORT CENTER DRIVE , NEWPORT BEACH , CA, US
92660
(Street and Number or P.O. Box) (City or Town, State, Country
and Zip Code)
Primary Location of Books and Records 700 NEWPORT CENTER DRIVE
(Street and Number)
NEWPORT BEACH , CA, US 92660 , 949-219-3011 (City or Town,
State, Country and Zip Code) (Area Code) (Telephone Number)
Internet Website Address WWW.PACIFICLIFE.COM
Statutory Statement Contact JENNIFER LYNN ST. ONGE ,
949-219-3312
(Name) (Area Code) (Telephone Number) JENNIFER.ST.ONGE
@PACIFICLIFE.COM , 949-219-5246
(E-mail Address) (FAX Number)
OFFICERS Chairman, President & Chief Executive Officer JAMES
THOMAS MORRIS
Executive Vice President & Chief Financial Officer DARRYL
DOUGLAS BUTTON
Senior Vice President & Chief Accounting Officer JOSHUA D
SCOTT #
OTHER
JANE MARIE GUON
Vice President & Secretary CRAIG WILSON LESLIE # Vice
President & Treasurer
DIRECTORS OR TRUSTEES
DARRYL DOUGLAS BUTTON SHARON ANN CHEEVER ADRIAN SCOTT GRIGGS
LAWRENCE FRANCIS HARR JAMES THOMAS MORRIS
The officers of this reporting entity being duly sworn, each
depose and say that they are the described officers of said
reporting entity, and that on the reporting period stated above,
all of the herein described assets were the absolute property of
the said reporting entity, free and clear from any liens or claims
thereon, except as herein stated, and that this statement, together
with related exhibits, schedules and explanations therein
contained, annexed or referred to, is a full and true statement of
all the assets and liabilities and of the condition and affairs of
the said reporting entity as of the reporting period stated above,
and of its income and deductions therefrom for the period ended,
and have been completed in accordance with the NAIC Annual
Statement Instructions and Accounting Practices and Procedures
manual except to the extent that: (1) state law may differ; or, (2)
that state rules or regulations require differences in reporting
not related to accounting practices and procedures, according to
the best of their information, knowledge and belief, respectively.
Furthermore, the scope of this attestation by the described
officers also includes the related corresponding electronic filing
with the NAIC, when required, that is an exact copy (except for
formatting differences due to electronic filing) of the enclosed
statement. The electronic filing may be requested by various
regulators in lieu of or in addition to the enclosed statement.
James Thomas Morris Darryl Douglas Button Joshua D Scott
Chairman, President & Chief Executive Officer Executive Vice
President & Chief Financial Officer Senior Vice President &
Chief Accounting Officer
a. Is this an original filing? .................. Yes [ ] No [ X
] b. If no,
1. State the amendment number ..... 2 2. Date filed
.................................... 4th day of June, 2020 3.
Number of pages attached .......... 1
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
ASSETSCurrent Statement Date 4
1
Assets
2
Nonadmitted Assets
3Net Admitted Assets
(Cols. 1 - 2)
December 31Prior Year Net
Admitted Assets
1. Bonds 55,254,673,649 55,254,673,649 53,042,350,247
2. Stocks:
2.1 Preferred stocks 7,531,819 7,531,819 10,731,507
2.2 Common stocks 933,891,753 157,722,217 776,169,536
800,846,496
3. Mortgage loans on real estate:
3.1 First liens 14,068,049,676 14,068,049,676 13,684,963,866
3.2 Other than first liens
4. Real estate:
4.1 Properties occupied by the company (less $
encumbrances) 107,479,522 107,479,522 109,259,198
4.2 Properties held for the production of income (less
$ encumbrances) 30,090,928 30,090,928 30,374,953
4.3 Properties held for sale (less $
encumbrances)
5. Cash ($ 121,251,641 ), cash equivalents
($ 1,733,953,692 ) and short-term
investments ($ 1,265,493 ) 1,856,470,826 1,856,470,826
3,710,559,929
6. Contract loans (including $ premium notes) 8,159,236,083
1,621,392 8,157,614,691 7,940,193,877
7. Derivatives 1,178,044,622 1,178,044,622 1,084,988,414
8. Other invested assets 3,725,198,953 20,100,383 3,705,098,570
3,695,973,430
9. Receivables for securities 74,966,933 74,966,933
23,240,171
10. Securities lending reinvested collateral assets
2,038,636,735 2,038,636,735 2,130,824,920
11. Aggregate write-ins for invested assets 31,020,074
31,020,074 10,642,501
12. Subtotals, cash and invested assets (Lines 1 to 11)
87,465,291,574 179,443,991 87,285,847,583 86,274,949,509
13. Title plants less $ charged off (for Title insurers
only)
14. Investment income due and accrued 669,225,489 669,225,489
620,381,973
15. Premiums and considerations:
15.1 Uncollected premiums and agents' balances in the course of
collection 204,317,843 531,983 203,785,860 141,921,618
15.2 Deferred premiums, agents' balances and installments booked
but
deferred and not yet due (including $
earned but unbilled premiums) 119,929,085 119,929,085
165,356,342
15.3 Accrued retrospective premiums ($ ) and
contracts subject to redetermination ($ )
16. Reinsurance:
16.1 Amounts recoverable from reinsurers 248,423,180 7,596,761
240,826,419 170,565,447
16.2 Funds held by or deposited with reinsured companies
233,157,127 233,157,127 263,265,833
16.3 Other amounts receivable under reinsurance contracts
96,339,882 96,339,882 132,039,731
17. Amounts receivable relating to uninsured plans
18.1 Current federal and foreign income tax recoverable and
interest thereon 1,590,939
18.2 Net deferred tax asset 564,487,880 321,579,333 242,908,547
313,708,418
19. Guaranty funds receivable or on deposit 1,858,149 1,858,149
1,907,786
20. Electronic data processing equipment and software 65,640,025
62,398,951 3,241,074 3,728,910
21. Furniture and equipment, including health care delivery
assets
($ ) 9,773,723 9,773,723
22. Net adjustment in assets and liabilities due to foreign
exchange rates
23. Receivables from parent, subsidiaries and affiliates
44,259,200 44,259,200 34,840,548
24. Health care ($ ) and other amounts receivable 124,929,197
14,094,197 110,835,000 93,030,692
25. Aggregate write-ins for other than invested assets
181,463,705 33,979,992 147,483,713 177,020,596
26. Total assets excluding Separate Accounts, Segregated
Accounts and Protected Cell Accounts (Lines 12 to 25)
90,029,096,059 629,398,932 89,399,697,127 88,394,308,341
27. From Separate Accounts, Segregated Accounts and Protected
Cell Accounts 48,156,641,169 48,156,641,169 57,266,846,432
28. Total (Lines 26 and 27) 138,185,737,228 629,398,932
137,556,338,296 145,661,154,773
DETAILS OF WRITE-INS
1101. Derivatives collateral receivable 31,020,074 31,020,074
10,642,501
1102.
1103.
1198. Summary of remaining write-ins for Line 11 from overflow
page
1199. Totals (Lines 1101 through 1103 plus 1198)(Line 11 above)
31,020,074 31,020,074 10,642,501
2501. Prepaid pension costs 1,219,003 1,219,003
2502. Cash value of life insurance policies 118,908,585
118,908,585 149,501,659
2503. Accounts and notes receivable 13,027,862 13,027,862
12,443,024
2598. Summary of remaining write-ins for Line 25 from overflow
page 48,308,255 32,760,989 15,547,266 15,075,912
2599. Totals (Lines 2501 through 2503 plus 2598)(Line 25 above)
181,463,705 33,979,992 147,483,713 177,020,596
2
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
LIABILITIES, SURPLUS AND OTHER FUNDS1
CurrentStatement Date
2December 31
Prior Year
1. Aggregate reserve for life contracts $ 68,853,153,817 less $
included in Line 6.3
(including $ 6,026,973,579 Modco Reserve) 68,853,153,817
67,668,847,081
2. Aggregate reserve for accident and health contracts
(including $ Modco Reserve) 17,851,028 17,855,322
3. Liability for deposit-type contracts (including $ Modco
Reserve) 4,306,564,955 4,118,556,222
4. Contract claims:
4.1 Life 894,216,344 990,103,048
4.2 Accident and health
5. Policyholders’ dividends/refunds to members $ 322,291 and
coupons $ due
and unpaid 322,291 287,166
6. Provision for policyholders’ dividends, refunds to members
and coupons payable in following calendar year - estimated
amounts:
6.1 Policyholders’ dividends and refunds to members apportioned
for payment (including $
Modco) 8,625,281 8,757,577
6.2 Policyholders’ dividends and refunds to members not yet
apportioned (including $ Modco) 1,032,340 991,361
6.3 Coupons and similar benefits (including $ Modco)
7. Amount provisionally held for deferred dividend policies not
included in Line 6
8. Premiums and annuity considerations for life and accident and
health contracts received in advance less
$ discount; including $ accident and health premiums 4,113,390
2,036,637
9. Contract liabilities not included elsewhere:
9.1 Surrender values on canceled contracts 9.2 Provision for
experience rating refunds, including the liability of $ accident
and health
experience rating refunds of which $ is for medical loss ratio
rebate per the Public Health
Service Act
9.3 Other amounts payable on reinsurance, including $ 82,394,368
assumed and $ 235,468,515
ceded 317,862,883 201,483,810
9.4 Interest Maintenance Reserve 184,971,822 180,203,758
10. Commissions to agents due or accrued-life and annuity
contracts $ 17,622,932 , accident and health
$ and deposit-type contract funds $ 3,137,210 20,760,142
40,113,776
11. Commissions and expense allowances payable on reinsurance
assumed 15,424,766 16,195,690
12. General expenses due or accrued 189,541,547 272,806,172
13. Transfers to Separate Accounts due or accrued (net)
(including $ (698,359,324) accrued for expense
allowances recognized in reserves, net of reinsured allowances)
(791,528,409) (779,849,491)
14. Taxes, licenses and fees due or accrued, excluding federal
income taxes 5,238,934 7,408,206
15.1 Current federal and foreign income taxes, including $
75,334,266 on realized capital gains (losses) 239,362,138
342,884,801
15.2 Net deferred tax liability
16. Unearned investment income 163,137,795 231,176,810
17. Amounts withheld or retained by reporting entity as agent or
trustee 153,845,064 213,340,166
18. Amounts held for agents' account, including $ agents' credit
balances
19. Remittances and items not allocated 51,705,698
47,649,476
20. Net adjustment in assets and liabilities due to foreign
exchange rates
21. Liability for benefits for employees and agents if not
included above 209,276,884 211,636,986
22. Borrowed money $ 49,387,794 and interest thereon $ 192,903
49,580,697 49,826,132
23. Dividends to stockholders declared and unpaid
24. Miscellaneous liabilities:
24.01 Asset valuation reserve 731,812,639 727,945,104
24.02 Reinsurance in unauthorized and certified ($ ) companies
3,940,216 1,323,618
24.03 Funds held under reinsurance treaties with unauthorized
and certified ($ ) reinsurers 152,730,157 108,285,349
24.04 Payable to parent, subsidiaries and affiliates 2,429,112
2,985,431
24.05 Drafts outstanding
24.06 Liability for amounts held under uninsured plans
24.07 Funds held under coinsurance 132,653,469 124,944,273
24.08 Derivatives 197,019,013 91,385,026
24.09 Payable for securities 97,205,977 17,214,293
24.10 Payable for securities lending 2,038,636,735
2,130,824,920
24.11 Capital notes $ and interest thereon $
25. Aggregate write-ins for liabilities 782,452,588
837,488,802
26. Total liabilities excluding Separate Accounts business
(Lines 1 to 25) 79,033,939,314 77,884,707,522
27. From Separate Accounts Statement 48,156,641,169
57,266,846,432
28. Total liabilities (Lines 26 and 27) 127,190,580,483
135,151,553,954
29. Common capital stock 30,000,000 30,000,000
30. Preferred capital stock
31. Aggregate write-ins for other than special surplus funds
136,678,833 138,567,931
32. Surplus notes 1,674,191,096 1,730,101,977
33. Gross paid in and contributed surplus 1,185,788,610
1,185,788,610
34. Aggregate write-ins for special surplus funds
35. Unassigned funds (surplus) 7,339,099,274 7,425,142,302
36. Less treasury stock, at cost:
36.1 shares common (value included in Line 29 $ )
36.2 shares preferred (value included in Line 30 $ )
37. Surplus (Total Lines 31+32+33+34+35-36) (including $ in
Separate Accounts Statement) 10,335,757,813 10,479,600,820
38. Totals of Lines 29, 30 and 37 10,365,757,813
10,509,600,820
39. Totals of Lines 28 and 38 (Page 2, Line 28, Col. 3)
137,556,338,296 145,661,154,773
DETAILS OF WRITE-INS
2501. Derivatives collateral payable and income accruals
719,249,153 760,739,726
2502. Disbursements payable 21,955,839 39,740,956
2503. Unclaimed accounts and uncashed checks 18,739,859
17,792,112
2598. Summary of remaining write-ins for Line 25 from overflow
page 22,507,737 19,216,007
2599. Totals (Lines 2501 through 2503 plus 2598)(Line 25 above)
782,452,588 837,488,802
3101. Other surplus adjustments - derivatives 136,678,833
138,567,931
3102.
3103.
3198. Summary of remaining write-ins for Line 31 from overflow
page
3199. Totals (Lines 3101 through 3103 plus 3198)(Line 31 above)
136,678,833 138,567,931
3401.
3402.
3403.
3498. Summary of remaining write-ins for Line 34 from overflow
page
3499. Totals (Lines 3401 through 3403 plus 3498)(Line 34
above)
3
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
SUMMARY OF OPERATIONS1
Current YearTo Date
2Prior YearTo Date
3Prior Year Ended
December 31
1. Premiums and annuity considerations for life and accident and
health contracts 2,899,670,624 3,551,703,490 13,440,677,886
2. Considerations for supplementary contracts with life
contingencies 875,617
3. Net investment income 928,793,479 668,456,345
3,829,565,211
4. Amortization of Interest Maintenance Reserve (IMR) 4,883,605
3,542,846 15,587,404
5. Separate Accounts net gain from operations excluding
unrealized gains or losses
6. Commissions and expense allowances on reinsurance ceded
34,427,046 38,985,662 178,960,324
7. Reserve adjustments on reinsurance ceded (245,973,774)
(251,703,371) (931,997,371)
8. Miscellaneous Income:
8.1 Income from fees associated with investment management,
administration and contract guarantees from Separate Accounts
292,287,364 292,631,836 1,207,775,282
8.2 Charges and fees for deposit-type contracts 12,750,916
4,652,260 32,438,872
8.3 Aggregate write-ins for miscellaneous income 29,275,264
64,580,083 232,563,556
9. Totals (Lines 1 to 8.3) 3,956,114,524 4,372,849,150
18,006,446,781
10. Death benefits 375,960,351 359,008,598 1,609,419,201
11. Matured endowments (excluding guaranteed annual pure
endowments) 76,821 (527,199) 226,339
12. Annuity benefits 262,679,058 220,883,524 944,910,744
13. Disability benefits and benefits under accident and health
contracts 1,388,406 1,935,451 5,143,144
14. Coupons, guaranteed annual pure endowments and similar
benefits
15. Surrender benefits and withdrawals for life contracts
1,877,580,600 1,802,294,370 7,387,680,280
16. Group conversions
17. Interest and adjustments on contract or deposit-type
contract funds 34,908,799 28,199,006 122,950,642
18. Payments on supplementary contracts with life contingencies
644,432 80,430 394,303
19. Increase in aggregate reserves for life and accident and
health contracts 1,453,116,644 2,196,991,609 7,754,644,017
20. Totals (Lines 10 to 19) 4,006,355,111 4,608,865,789
17,825,368,670
21. Commissions on premiums, annuity considerations, and
deposit-type contract funds (direct business only) 271,466,165
262,716,114 1,122,715,213
22. Commissions and expense allowances on reinsurance assumed
3,620,025 5,347,337 20,439,758
23. General insurance expenses and fraternal expenses
246,243,151 192,638,476 861,608,693
24. Insurance taxes, licenses and fees, excluding federal income
taxes 35,864,305 30,464,754 113,278,462
25. Increase in loading on deferred and uncollected premiums
6,503,068 824,739 1,628,948
26. Net transfers to or (from) Separate Accounts net of
reinsurance (487,640,012) (828,060,145) (2,754,460,302)
27. Aggregate write-ins for deductions 34,872,084 (10,336,782)
(12,089,161)
28. Totals (Lines 20 to 27) 4,117,283,897 4,262,460,281
17,178,490,281
29. Net gain from operations before dividends to policyholders
and federal income taxes (Line 9 minus Line 28) (161,169,373)
110,388,869 827,956,500
30. Dividends to policyholders and refunds to members 2,312,661
2,535,719 9,088,294
31. Net gain from operations after dividends to policyholders,
refunds to members and before federal income taxes (Line 29 minus
Line 30) (163,482,034) 107,853,151 818,868,206
32. Federal and foreign income taxes incurred (excluding tax on
capital gains) (163,572,569) (16,964,277) (50,498,857)
33. Net gain from operations after dividends to policyholders,
refunds to members and federal income taxes and before realized
capital gains or (losses) (Line 31 minus Line 32) 90,535
124,817,428 869,367,063
34. Net realized capital gains (losses) (excluding gains
(losses) transferred to the IMR) less capital
gains tax of $ 75,107,873 (excluding taxes of $ 226,393
transferred to the IMR) (317,228,794) 285,209,792
846,512,498
35. Net income (Line 33 plus Line 34) (317,138,259) 410,027,219
1,715,879,561
CAPITAL AND SURPLUS ACCOUNT
36. Capital and surplus, December 31, prior year 10,509,600,820
9,691,434,433 9,691,434,433
37. Net income (Line 35) (317,138,259) 410,027,219
1,715,879,561
38. Change in net unrealized capital gains (losses) less capital
gains tax of $ 7,047,801 26,190,287 39,799,071 (547,043,354)
39. Change in net unrealized foreign exchange capital gain
(loss) (1,356,439) (3,436,708) (3,395,349)
40. Change in net deferred income tax (40,696,101) (77,566,271)
(47,312,823)
41. Change in nonadmitted assets 12,287,013 41,706,104
23,941,716
42. Change in liability for reinsurance in unauthorized and
certified companies (616,639) (4,212,152) (912,684)
43. Change in reserve on account of change in valuation basis,
(increase) or decrease 238,524,319 59,509,614 59,509,614
44. Change in asset valuation reserve (3,867,536) (47,924,620)
210,302,378
45. Change in treasury stock
46. Surplus (contributed to) withdrawn from Separate Accounts
during period
47. Other changes in surplus in Separate Accounts Statement
48. Change in surplus notes (55,910,881) 47,119 188,477
49. Cumulative effect of changes in accounting principles
64,855,334
50. Capital changes:
50.1 Paid in
50.2 Transferred from surplus (Stock Dividend)
50.3 Transferred to surplus
51. Surplus adjustment:
51.1 Paid in
51.2 Transferred to capital (Stock Dividend)
51.3 Transferred from capital
51.4 Change in surplus as a result of reinsurance
52. Dividends to stockholders (650,000,000)
53. Aggregate write-ins for gains and losses in surplus
(1,258,772) (2,031,755) (7,846,483)
54. Net change in capital and surplus for the year (Lines 37
through 53) (143,843,007) 415,917,621 818,166,387
55. Capital and surplus, as of statement date (Lines 36 + 54)
10,365,757,813 10,107,352,054 10,509,600,820
DETAILS OF WRITE-INS
08.301. Fee income 25,328,713 48,298,244 179,573,030
08.302. Miscellaneous income 3,946,551 16,281,838 52,990,526
08.303.
08.398. Summary of remaining write-ins for Line 8.3 from
overflow page
08.399. Totals (Lines 08.301 through 08.303 plus 08.398) (Line
8.3 above) 29,275,264 64,580,083 232,563,556
2701. Net periodic benefit cost 1,500,208 2,534,733
12,298,875
2702. Miscellaneous disbursements 33,314,708 (12,916,290)
(21,983,255)
2703. Contingency expense 57,168 44,775 (2,404,781)
2798. Summary of remaining write-ins for Line 27 from overflow
page
2799. Totals (Lines 2701 through 2703 plus 2798)(Line 27 above)
34,872,084 (10,336,782) (12,089,161)
5301. Adjustments to retirement plans 1,061,683 (234,306)
(520,717)
5302. Other surplus adjustments - derivatives (1,889,098)
(1,797,449) (7,325,766)
5303. Miscellaneous surplus transfers (431,357)
5398. Summary of remaining write-ins for Line 53 from overflow
page
5399. Totals (Lines 5301 through 5303 plus 5398)(Line 53 above)
(1,258,772) (2,031,755) (7,846,483)
4
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
CASH FLOW1
Current YearTo Date
2Prior YearTo Date
3Prior Year Ended
December 31
Cash from Operations
1. Premiums collected net of reinsurance 2,878,751,716
3,502,491,056 13,218,335,726
2. Net investment income 864,083,942 540,054,049
3,806,317,916
3. Miscellaneous income 170,779,089 240,219,177 805,778,478
4. Total (Lines 1 to 3) 3,913,614,747 4,282,764,281
17,830,432,120
5. Benefit and loss related payments 2,603,377,699 2,459,938,757
9,880,751,998
6. Net transfers to Separate Accounts, Segregated Accounts and
Protected Cell Accounts (475,961,095) (837,678,638)
(2,751,795,570)
7. Commissions, expenses paid and aggregate write-ins for
deductions 715,739,090 596,549,546 2,075,310,977
8. Dividends paid to policyholders 2,368,853 2,656,509
8,926,716
9. Federal and foreign income taxes paid (recovered) net of $
tax on capital
gains (losses) 13,693,100 4,094,432 (818,800,643)
10. Total (Lines 5 through 9) 2,859,217,648 2,225,560,606
8,394,393,477
11. Net cash from operations (Line 4 minus Line 10)
1,054,397,099 2,057,203,676 9,436,038,643
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
12.1 Bonds 971,269,961 1,784,824,254 5,863,449,877
12.2 Stocks 3,000,010 25,065,838 40,084,234
12.3 Mortgage loans 194,677,018 329,486,882 1,252,799,112
12.4 Real estate
12.5 Other invested assets 380,181,039 345,684,794
2,364,155,888
12.6 Net gains or (losses) on cash, cash equivalents and
short-term investments (283,550) 9,973 (12,058)
12.7 Miscellaneous proceeds 696,519,959 450,860,645
1,343,034,977
12.8 Total investment proceeds (Lines 12.1 to 12.7)
2,245,364,437 2,935,932,386 10,863,512,030
13. Cost of investments acquired (long-term only):
13.1 Bonds 3,274,982,380 2,993,773,767 11,157,269,236
13.2 Stocks 16,132,086 41,850,720 159,071,947
13.3 Mortgage loans 606,773,010 881,123,017 2,728,251,442
13.4 Real estate 71,246 38,294 881,366
13.5 Other invested assets 367,357,389 553,062,310
2,161,953,793
13.6 Miscellaneous applications 659,272,030 434,569,417
1,431,273,484
13.7 Total investments acquired (Lines 13.1 to 13.6)
4,924,588,141 4,904,417,525 17,638,701,267
14. Net increase (or decrease) in contract loans and premium
notes 217,790,275 (55,419,289) (25,872,003)
15. Net cash from investments (Line 12.8 minus Line 13.7 and
Line 14) (2,897,013,979) (1,913,065,850) (6,749,317,234)
Cash from Financing and Miscellaneous Sources
16. Cash provided (applied):
16.1 Surplus notes, capital notes (55,958,000)
16.2 Capital and paid in surplus, less treasury stock
16.3 Borrowed funds (245,436) (50,233,403) (50,951,473)
16.4 Net deposits on deposit-type contracts and other insurance
liabilities 155,902,289 11,241,008 334,610,013
16.5 Dividends to stockholders 650,000,000
16.6 Other cash provided (applied) (111,171,076) 143,500,742
820,290,961
17. Net cash from financing and miscellaneous sources (Line 16.1
through Line 16.4 minus Line 16.5 plus Line 16.6) (11,472,223)
104,508,346 453,949,502
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS
18. Net change in cash, cash equivalents and short-term
investments (Line 11, plus Lines 15 and 17) (1,854,089,103)
248,646,171 3,140,670,910
19. Cash, cash equivalents and short-term investments:
19.1 Beginning of year 3,710,559,929 569,889,019 569,889,019
19.2 End of period (Line 18 plus Line 19.1) 1,856,470,826
818,535,191 3,710,559,929
Note: Supplemental disclosures of cash flow information for
non-cash transactions:
20.0001. Bonds disposed and acquired 38,303,769 200,143,446
1,094,930,292
20.0002. Stocks disposed and acquired 180,900 25,074,500
20.0003. Mortgage loans disposed and acquired 786,640
87,468,493
20.0004. Bond interest in-kind received 2,650,284 1,632,691
7,250,620
20.0005. Other invested assets in-kind received 59,971
20.0006. Transfer of other invested assets between Pacific Life
to an affiliated private equity
fund 3,463,902
20.0007. Assets in-kind received as premiums 221,411,731
5
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
EXHIBIT 1
DIRECT PREMIUMS AND DEPOSIT-TYPE CONTRACTS1
Current YearTo Date
2Prior YearTo Date
3Prior Year Ended
December 31
1. Industrial life
2. Ordinary life insurance 954,012,946 844,571,245
3,878,976,632
3. Ordinary individual annuities 2,030,487,658 2,200,714,005
8,166,993,268
4. Credit life (group and individual)
5. Group life insurance
6. Group annuities 16,007,145 559,887,163 1,854,189,142
7. A & H - group
8. A & H - credit (group and individual)
9. A & H - other
10. Aggregate of all other lines of business
11. Subtotal (Lines 1 through 10) 3,000,507,749 3,605,172,413
13,900,159,041
12. Fraternal (Fraternal Benefit Societies Only)
13. Subtotal (Lines 11 through 12) 3,000,507,749 3,605,172,413
13,900,159,041
14. Deposit-type contracts 258,326,321 96,648,036
691,387,881
15. Total (Lines 13 and 14) 3,258,834,070 3,701,820,449
14,591,546,922
DETAILS OF WRITE-INS
1001.
1002.
1003.
1098. Summary of remaining write-ins for Line 10 from overflow
page
1099. Totals (Lines 1001 through 1003 plus 1098)(Line 10
above)
6
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND GOING
CONCERN
A. Accounting Practices:
Pacific Life Insurance Company (the Company or Pacific Life)
prepares its financial statements based on accounting practices
prescribed or permitted by the Nebraska Department of Insurance (NE
DOI). The National Association of Insurance Commissioners’ (NAIC)
Accounting Practices and Procedures Manual (NAIC SAP) has been
adopted as a component of prescribed or permitted practices by the
NE DOI. Prescribed statutory accounting practices include state
laws and regulations. Additionally, the Director of the NE DOI has
the right to permit other specific practices, which deviate from
prescribed practices.
The following table reconciles the Company’s net income for the
three months ended March 31, 2020 and the year ended December 31,
2019 and statutory surplus as of March 31, 2020 and December 31,
2019, between NAIC SAP and practices prescribed and permitted by
the NE DOI:
SSAP F/S F/S March 31, December 31,# Page Line 2020 2019
NET INCOME1. Net Income, Nebraska Basis (Page 4, Line 35,
Columns 1 & 3) XXX XX
XXXX ($317,138,259) $1,715,879,561
2. State Prescribed Practices That Are an Increase/(Decrease)
fromNAIC SAP: 0 0
3. State Permitted Practices That Are an Increase/(Decrease)
fromNAIC SAP: 0 0
4. Net Income, NAIC SAP (1-2-3=4) XXX XXX
XXX ($317,138,259) $1,715,879,561
SURPLUS5. Statutory Surplus, Nebraska Basis (Page 3, Line 38,
Columns 1 & 2) XXX XX
XXXX $10,365,757,813 $10,509,600,820
6. State Prescribed Practices That Are an Increase/(Decrease)
fromNAIC SAP: 0 0
7. State Permitted Practices That Are an Increase/(Decrease)
fromNAIC SAP: 0 0
8. Statutory Surplus, NAIC SAP (5-6-7=8) XXX XXX
XXX $10,365,757,813 $10,509,600,820
B. No significant change
C. Accounting Policies:
1. No significant change
2. Bonds not backed by other loans are generally stated at
amortized cost using the effective interest method. Bonds,
including loan-backed and structured securities (LBASS), with a
NAIC designation of 6 are stated at the lower of amortized cost or
fair value with changes in fair value recorded in unassigned
surplus as a change in net unrealized capital gains (losses) less
tax.
3-5. No significant change
6. LBASS are generally stated at amortized cost using the
effective interest method. Income is determined considering
anticipated cash flows based on industry prepayment models and
internal estimates. These assumptions are consistent with the
current interest rate and economic conditions at the time of
valuation. For LBASS purchased with high credit quality and fixed
interest rates, the effective yield is recalculated on a
retrospective basis. For all other LBASS, including those where
cash flows are deemed other than temporarily impaired, effective
yield is recalculated on a prospective basis.
7-13. No significant change
D. Going Concern: The Company is not aware of any current
situation or event that would cause substantial doubt about its
ability to continue as a going concern.
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.1
2. ACCOUNTING CHANGES AND CORRECTIONS OF ERRORS
Effective January 1, 2017, Statement of Statutory Accounting
Principles (SSAP) No. 51R, Life Contracts, was issued which made
substantive revisions to SSAP No. 51 to reference the Valuation
Manual as part of Principle-Based Reserve (PBR) implementation. For
life insurance policies issued during 2017-2019, the Valuation
Manual did not require companies to update their reserve
methodologies during the first three years following the operative
date of the Valuation Manual. The Company implemented PBR for all
life insurance policies issued in 2020. The Company implemented PBR
for certain life insurance policies issued in 2019 which did not
have a material impact on the financial statements.
Additionally, variable annuity contracts are subject to
Actuarial Guideline 43 (AG43) and the Valuation Manual section
VM-21 (VM-21). As a result of updates to AG43 and VM-21, effective
January 1, 2020, for all variable annuity contracts, $238.5 million
of reserves were released with an offsetting adjustment in surplus,
change in reserve on account of change in valuation basis,
(increase) or decrease (page 4, line 43).
During the three months ended March 31, 2020, the Company
determined the balances for Amounts Recoverable From Reinsurers
(page 2, line 16.1) and Other Amounts Receivable Under Reinsurance
Contracts (page 2, line 16.3) as well as Other Amounts Payable on
Reinsurance (page 3, line 9.3) were not properly presented as of
December 31, 2019, which have not been restated. This resulted in
an understatement of Amounts Recoverable From Reinsurers (page 2,
line 16.1) and Other Amounts Payable on Reinsurance (page 3, line
9.3) of $108 million and $87 million, respectively, and an
overstatement of Other Amounts Receivable Under Reinsurance
Contracts (page 2, line 16.3) of $21 million as of December 31,
2019. This also resulted in an understatement of Miscellaneous
Income (page 5, line 3) and Benefit and Loss Related Payments (page
5, line 5) of $21 million in the Cash Flow statement for the year
ended December 31, 2019. These lines on the Assets and Liabilities,
Surplus and Other Funds statements and Cash Flow statement are
properly presented as of and for the three months ended March 31,
2020. There was no impact to surplus or the Summary of
Operations.
3. BUSINESS COMBINATIONS AND GOODWILL
No significant change
4. DISCONTINUED OPERATIONS
No significant change
5. INVESTMENTS
A. Mortgage Loans, Including Mezzanine Real Estate Loans
1. The maximum and minimum lending rates for new mortgage loans
during 2020 were:
Maximum Minimuma. Farm 4.75% 3.75%b. Construction and Land
Development 0.00% 0.00%c. Multi-family Residential 0.00% 0.00%d.
Commercial 5.00% 2.85%
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.2
2-3. No significant change
4. Age Analysis of Mortgage Loans and Identification of Mortgage
Loans in Which the Insurer is a Participant or Co-lender in a
Mortgage Loan Agreement:
Residential CommercialFarm Insured All Other Insured All Other
Mezzanine Total
a. Current Year1. Recorded Investment (All)
(a) Current $570,980,549 $0 $220,195,739 $0 $13,166,270,943
$106,663,831 $14,064,111,062(b) 30-59 Days Past Due 0 0 592,715 0 0
0 592,715(c) 60-89 Days Past Due 0 0 0 0 0 0 0(d) 90-179 Days Past
Due 3,345,899 0 0 0 0 0 3,345,899(e) 180+ Days Past Due 0 0 0 0 0 0
0
2. Accruing Interest 90-179Days Past Due(a) Recorded Investment
$3,345,899 $0 $0 $0 $0 $0 $3,345,899(b) Interest Accrued 105,674 0
0 0 0 0 105,674
3. Accruing Interest 180+ DaysPast Due(a) Recorded Investment $0
$0 $0 $0 $0 $0 $0(b) Interest Accrued 0 0 0 0 0 0 0
4. Interest Reduced(a) Recorded Investment $0 $0 $0 $0 $0 $0
$0(b) Number of Loans 0 0 0 0 0 0 0(c) Percent Reduced 0% 0% 0% 0%
0% 0% 0%
5. Participant or Co-lender in aMortgage Loan Agreement(a)
Recorded Investment (1) $0 $0 $0 $0 $1,490,811,006 $106,663,831
$1,597,474,837
b. Prior Year1. Recorded Investment
(a) Current $533,658,733 $0 $222,459,793 $0 $12,822,199,253
$106,646,087 $13,684,963,866(b) 30-59 Days Past Due 0 0 0 0 0 0
0(c) 60-89 Days Past Due 0 0 0 0 0 0 0(d) 90-179 Days Past Due 0 0
0 0 0 0 0(e) 180+ Days Past Due 0 0 0 0 0 0 0
2. Accruing Interest 90-179Days Past Due(a) Recorded Investment
$0 $0 $0 $0 $0 $0 $0(b) Interest Accrued 0 0 0 0 0 0 0
3. Accruing Interest 180+ DaysPast Due(a) Recorded Investment $0
$0 $0 $0 $0 $0 $0(b) Interest Accrued 0 0 0 0 0 0 0
4. Interest Reduced(a) Recorded Investment $0 $0 $0 $0 $0 $0
$0(b) Number of Loans 0 0 0 0 0 0 0(c) Percent Reduced 0% 0% 0% 0%
0% 0% 0%
5. Participant or Co-lender in aMortgage Loan Agreement(a)
Recorded Investment (1) $0 $0 $0 $0 $1,309,826,465 $106,646,087
$1,416,472,552
(1) Excluded from the Commercial All Other amounts are mortgage
loan participations where the sole participants are the Company and
its wholly- owned subsidiary, Pacific Life & Annuity Company
(PL&A). The total amounts were $2,824 million and $2,831
million at March 31, 2020 and December 31, 2019, respectively.
5-9. No significant change
B-C. No significant change
D. Loan-backed Securities:
1. Prepayment assumptions for LBASS were obtained from industry
prepayment models and internal estimates. These assumptions are
consistent with the current interest rate and economic conditions
at the time of valuation.
2. No other than temporary impairments (OTTIs) were recognized
on LBASS due to intent to sell or inability or lack of intent to
retain the investment in the security for a period of time
sufficient to recover the amortized cost basis.
3. The Company had no OTTI recognized on its LBASS
investments.
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.3
4. The unrealized losses of LBASS where fair value is less than
cost or amortized cost for which an OTTI has not been recognized in
earnings as of March 31, 2020 are as follows:
March 31,2020
a. The Aggregate Amount of Unrealized Losses:1. Less than 12
Months $353,693,9502. 12 Months or Longer 69,310,273
b. The Aggregate Related Fair Valueof Securities with Unrealized
Losses: 1. Less than 12 Months $5,214,578,463
2. 12 Months or Longer 344,413,852
5. Additional Information: In determining whether a decline in
value is other than temporary, the Company considers several
factors including, but not limited to the following: the extent and
duration of the decline in value; the reasons for the decline
(credit event, currency, or interest rate related including spread
widening); the Company’s inability or lack of intent to retain the
investment for a period of time sufficient to recover the amortized
cost basis; and the performance of the security’s underlying
collateral and projected future cash flows. In projecting future
cash flows, the Company incorporates inputs from third-party
sources and applies reasonable judgment in developing assumptions
used to estimate the probability and timing of collecting all
contractual cash flows.
E. Dollar Repurchase Agreements and/or Securities Lending
Transactions
1-2. No significant change
3. Collateral Received
a. Aggregate Amount of Collateral Received
FairValue
1. Securities Lending (a) Open $2,038,636,735 (b) 30 Days or
Less 0 (c) 31 to 60 Days 0 (d) 61 to 90 Days 0 (e) Greater Than 90
Days 0 (f) Sub-total 2,038,636,735 (g) Securities Received 0 (h)
Total Collateral Received $2,038,636,735
2. Dollar Repurchase Agreement: None
b. The Company has not sold or repledged collateral received
from securities lending agreements.
c. No significant change
4. No significant change
5. Collateral Reinvestment
a. Aggregate Amount of Collateral Reinvested
Amortized FairCost Value
1. Securities Lending (a) Open $0 $0 (b) 30 Days or Less
538,636,735 538,636,735 (c) 31 to 60 Days 1,150,000,000
1,150,000,000 (d) 61 to 90 Days 0 0 (e) 91 to 120 Days 350,000,000
350,000,000 (f) 121 to 180 Days 0 0 (g) 181 to 365 Days 0 0 (h) 1
to 2 Years 0 0 (i) 2 to 3 Years 0 0 (j) Greater than 3 Years 0 0
(k) Sub-total 2,038,636,735 2,038,636,735 (l) Securities Received 0
0 (m) Total Collateral Reinvested $2,038,636,735 $2,038,636,735
2. Dollar Repurchase Agreement: None
b. No significant change
6-7. No significant change
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.4
F. The Company did not have any repurchase agreements
transactions accounted for as secured borrowing.
G. Reverse Repurchase Agreements Transactions Accounted for as a
Secured Borrowing:
1. The Company invests cash collateral received from its
securities lending activity into repurchase agreements. The Company
requires that all repurchase agreements must have a maximum
maturity of 95 days and the interest rate must reset no more than
monthly. All repurchase agreements must be collateralized by U.S.
Treasury Securities, U.S. Agency Securities, and/or U.S. Corporate
bonds with a minimum margin of 102%, and are marked to market on a
daily basis. Additionally, all repurchase agreements are
indemnified by the Company's securities lending agent against
counterparty default. When counterparty default and price movements
of the collateral received present the primary risks for repo
transactions, the Company is able to mitigate such risks by
mandating short tenure, commanding proper haircuts, marking to
market on a daily basis, and securing indemnification from a
financial institution with a strong financial profile.
2. Type of Repo Trades Used
First Quarter
(a) Bilateral (Yes/No) No(b) Tri-party (Yes/No) Yes
3. Original (Flow) & Residual Maturity
First Quarter
a. Maximum Amount(a) Open - No Maturity $0(b) Overnight
1,415,000,000(c) 2 Days to 1 Week 600,000,000(d) > 1 Week to 1
Month 600,000,000(e) > 1 Month to 3 Months 1,855,000,000(f) >
3 Months to 1 Year 350,000,000(g) > 1 Year 0
First Quarter
b. Ending Balance(a) Open - No Maturity $0(b) Overnight
50,000,000(c) 2 Days to 1 Week 0(d) > 1 Week to 1 Month
300,000,000(e) > 1 Month to 3 Months 1,150,000,000(f) > 3
Months to 1 Year 350,000,000(g) > 1 Year 0
4. The Company has not sold or acquired any securities that
resulted in default as of March 31, 2020.
5. Fair Value of Securities Acquired Under Repo-Secured
Borrowings
First Quarter
(a) Maximum Amount $3,894,763,566(b) Ending Balance
$2,001,592,306
6. Fair Value of Securities Acquired Under Repo-Secured
Borrowings by NAIC Designation
None NAIC 1 NAIC 2 NAIC 3ENDING BALANCE
(a) Bonds - FV $0 $375,186,617 $331,040,654 $778,995,103(b)
LBASS - FV 0 0 0 0(c) Preferred Stock - FV 0 0 0 0(d) Common Stock
- FV 0 0 0 0(e) Mortgage Loans - FV 0 0 0 0(f) Real Estate - FV 0 0
0 0(g) Derivatives - FV 0 0 0 0(h) Other Invested Assets - FV 0 0 0
0(i) Total Assets - FV $0 $375,186,617 $331,040,654
$778,995,103
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.5
NAIC 4 NAIC 5 NAIC 6
Does NotQualify as
NonadmittedENDING BALANCE
(a) Bonds - FV $516,369,932 $0 $0 $0(b) LBASS - FV 0 0 0 0(c)
Preferred Stock - FV 0 0 0 0(d) Common Stock - FV 0 0 0 0(e)
Mortgage Loans - FV 0 0 0 0(f) Real Estate - FV 0 0 0 0(g)
Derivatives - FV 0 0 0 0(h) Other Invested Assets - FV 0 0 0 0(i)
Total Assets - FV $516,369,932 $0 $0 $0
7. Collateral Provided - Secured Borrowing
First Quarter
a. Maximum Amount1. Cash $3,620,000,0002. Securities - FV 03.
Securities - BACV 04. Nonadmitted Subset - BACV 0
First Quarter
b. Ending Balance1. Cash $1,850,000,0002. Securities - FV 03.
Securities - BACV 04. Nonadmitted Subset - BACV 0
8. Allocation of Aggregate Collateral Pledged by Remaining
Contractual Maturity
AmortizedCost
FairValue
(a) Overnight and Continuous $0 $0(b) 30 Days or Less
350,000,000 350,000,000(c) 31- 90 Days 1,150,000,000
1,150,000,000(d) > 90 Days 350,000,000 350,000,000
9. Recognized Receivable for Return of Collateral - Secured
Borrowings
First Quarter
a. Maximum Amount1. Cash $3,620,000,0002. Securities - FV 0
First Quarter
b. Ending Balance1. Cash $1,850,000,0002. Securities - FV 0
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.6
10. Recognized Liability to Return Collateral-Secured Borrowings
(Total)
First Quarter
a. Maximum Amount1. Repo Securities Sold/Acquired
with Cash Collateral $3,620,000,0002. Repo Securities
Sold/Acquired
with Cash Collateral (FV) 0
First Quarter
b. Ending Balance1. Repo Securities Sold/Acquired
with Cash Collateral $1,850,000,0002. Repo Securities
Sold/Acquired
with Cash Collateral (FV) 0
H. The Company did not have any repurchase agreements
transactions accounted for as a sale.
I. The Company did not have any reverse purchase agreements
transactions accounted for as a sale.
J-K. No significant change
L. Restricted Assets:
1. Restricted Assets (Including Pledged)
Gross (Admitted & Nonadmitted) Restricted Percentage
Current Year
1 2 3 4 5 6 7 8 9 10 11
Restricted Asset Category
Total GeneralAccount(G/A)
G/ASupporting
S/AActivity
(a)
TotalSeparateAccount
(S/A)Restricted
Assets
S/A AssetsSupporting
G/AActivity
(b)Total
(1 plus 3)Total From
Prior Statement
Increase/(Decrease)(5 minus 6)
TotalNonadmitted
Restricted
Total Admitted Restricted
(5 minus 8)
Gross(Admitted &Nonadmitted)Restricted toTotal Assets
(c)
AdmittedRestrictedto Total
AdmittedAssets
(d)
a.
Subject to ContractualObligation for WhichLiability is Not
Shown
b.
Collateral Held UnderSecurity LendingAgreements $2,038,636,735
$2,038,636,735 $2,130,824,920 $(92,188,185) $2,038,636,735 1.476%
1.483%
c.Subject to RepurchaseAgreements
d.Subject to ReverseRepurchase Agreements
e.Subject to DollarRepurchase Agreements
f.Subject to Dollar ReverseRepurchase Agreements
g.Placed Under OptionContracts
h.Letter Stock or SecuritiesRestricted as to Sale
i. FHLB Capital Stock 5,568,100 5,568,100 4,739,500 828,600
5,568,100 0.004% 0.004%
j. On Deposit With States 6,057,573 6,057,573 6,059,510 (1,937)
6,057,573 0.004% 0.004%
k.On Deposit With OtherRegulatory Bodies
l.
Pledged Collateral toFHLB (Including AssetsBacking
FundingAgreements) 192,006,482 192,006,482 264,279,727 (72,273,245)
192,006,482 0.139% 0.140%
m.
Pledged as Collateral NotCaptured in OtherCategories 18,730,004
18,730,004 20,090,219 (1,360,215) 18,730,004 0.014% 0.014%
n. Other Restricted Assets
o. Total Restricted Assets $2,260,998,894 $2,260,998,894
$2,425,993,876 $(164,994,982) $2,260,998,894 1.637% 1.645%
(a) Subset of Column 1
(b) Subset of Column 3
(c) Column 5 Divided by Asset Page, Column 1, Line 28
(d) Column 9 Divided by Asset Page, Column 3, Line 28
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.7
2. Detail of Assets Pledged as Collateral Not Captured in Other
Categories (Contracts That Share Similar Characteristics, Such as
Reinsurance and Derivatives, Are Reported in the Aggregate)
Gross (Admitted & Nonadmitted) Restricted Percentage
Current Year
1 2 3 4 5 6 7 8 9 10
TotalGeneralAccount(G/A)
G/ASupporting
S/AActivity
(a)
Total SeparateAccount (S/A)
RestrictedAssets
S/A AssetsSupporting
G/AActivity
(b)Total
(1 plus 3)Total FromPrior Year
Increase/(Decrease)(5 minus 6)
TotalCurrent
YearAdmittedRestricted
Gross (Admitted& Nonadmitted)
Restricted toTotal Assets
AdmittedRestrictedto Total
AdmittedAssets
Pledged as Collateral forReinsurance Agreements $18,730,004
$18,730,004 $20,090,219 $(1,360,215) $18,730,004 0.014% 0.014%
Total $18,730,004 $18,730,004 $20,090,219 $(1,360,215)
$18,730,004 0.014% 0.014%
(a) Subset of column 1
(b) Subset of column 3
3. No significant change
4. Collateral Received and Reflected as Assets Within the
Reporting Entity’s Financial Statements:
1 2 3 4
Collateral Assets
Book/AdjustedCarrying Value
(BACV) Fair Value
% of BACV toTotal Assets(Admitted &Nonadmitted)
(*)
% of BACV toTotal Admitted
Assets(**)
General Account:
a.Cash, Cash Equivalents and Short-TermInvestments $487,176,565
$487,176,565 0.541% 0.545%
b. Schedule D, Part 1c. Schedule D, Part 2, Section 1d. Schedule
D, Part 2, Section 2e. Schedule Bf. Schedule Ag. Schedule BA, Part
1h. Schedule DL, Part 1 2,038,636,735 2,038,636,735 2.266% 2.282%i.
Otherj. Total Collateral Assets (a+b+c+d+e+f+g+h+i) $2,525,813,300
$2,525,813,300 2.807% 2.827%Separate Account:
k.Cash, Cash Equivalents and Short-TermInvestments
l. Schedule D, Part 1m. Schedule D, Part 2, Section 1m. Schedule
D, Part 2, Section 2o. Schedule Bp. Schedule Aq. Schedule BA, Part
1r. Schedule DL, Part 1s. Othert. Total Collateral Assets
(k+l+m+n+o+p+q+r+s) $0 $0 0.000% 0.000%
(*) j = Column 1 divided by Asset Page, Line 26, Column 1 t =
Column 1 divided by Asset Page, Line 27, Column 1(**) j = Column 1
divided by Asset Page, Line 26, Column 3 t = Column 1 divided by
Asset Page, Line 27, Column 3
1 2
Amount
% of Liability toTotal Liabilities
(*)u. Recognized Obligations to Return Collateral
Asset (General Account) $2,525,813,300 3.202%v. Recognized
Obligations to Return Collateral
Asset (Separate Account) $0 0.000%
(*) u = Column 1 divided by Liability Page, Line 26, Column 1 v
= Column 1 divided by Liability Page, Line 27, Column 1
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.8
M. Working Capital Finance Investments (WCFI):
1. Aggregate WCFI Book/Adjusted Carrying Value by NAIC
Designation
Gross AssetMarch 31, 2020
Nonadmitted AssetMarch 31, 2020
Net Admitted AssetMarch 31, 2020
a. WCFI Designation 1 $160,282,239 $0 $160,282,239b. WCFI
Designation 2 38,415,596 0 38,415,596c. WCFI Designation 3 0 0 0d.
WCFI Designation 4 0 0 0e. WCFI Designation 5 0 0 0f. WCFI
Designation 6 0 0 0g. Total $198,697,835 $0 $198,697,835
2. Aggregate Maturity Distribution on the Underlying Working
Capital Finance Programs (WCFP)
Book/AdjustedCarrying Value
a. Up to 180 Days $183,105,494b. 181 to 365 Days 15,592,341c.
Total $198,697,835
3. The Company did not have any events of default on working
capital finance investments.
N. The Company did not have any offsetting and netting of assets
and liabilities.
O-P. No significant change
Q. Prepayment Penalty and Acceleration Fees
General Account Separate Account
1. Number of CUSIPs 24 02. Aggregate Amount of Investment Income
$7,153,907 $0
6. JOINT VENTURES, PARTNERSHIPS AND LIMITED LIABILITY
COMPANIES
No significant change
7. INVESTMENT INCOME
No significant change
8. DERIVATIVE INSTRUMENTS
A. Derivatives Under SSAP No. 86, Derivatives
1-7. No significant change
8. For call options with premiums which are paid at the end of
the derivative contract, summarized in the tables below are the
undiscounted future settled premium commitments, call option fair
value and call option fair value excluding impact of discounted
future settled premiums:
Fiscal Year Premium Payments Due2020 $276,767,8742021
147,487,3392022 24,052,9952023 20,771,381Thereafter 24,921,277Total
Undiscounted FutureSettled Premium Commitments $494,000,866
Undiscounted Future PremiumCommitments
Derivative Fair Value(Reported on Schedule DB) (a)
Derivative Fair ValueExcluding Impact of
Discounted Future SettledPremiums
Prior Year - 2019 $458,014,520 $541,660,140 $781,594,142Current
Year - 2020 $494,000,866 $(22,128,027) $243,589,847
(a) The derivative fair value excludes accrued premium liability
of $228 million and $218 million as of March 31, 2020 and December
31, 2019, respectively.
B. The Company did not have any derivatives under SSAP No. 108,
Derivatives Hedging Variable Annuity Guarantees.
9. INCOME TAXES
No significant change
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.9
10. INFORMATION CONCERNING PARENT, SUBSIDIARIES, AFFILIATES AND
OTHER RELATED PARTIES
No significant change
11. DEBT
A. No significant change
B. FHLB (Federal Home Loan Bank) Agreements
1. The Company is a member of the FHLB. The Company is eligible
to receive advances from the FHLB based on a percentage of the
Company’s statutory general account assets provided it has
sufficient available eligible collateral and is in compliance with
the FHLB requirements, debt covenant restrictions and insurance
laws and regulations. The Company's estimated maximum borrowing
capacity (after taking into account required collateralization
levels) was $1.3 billion and $1.2 billion as of March 31, 2020 and
December 31, 2019, respectively. However, asset eligibility
determination is subject to the FHLB's discretion and to the
availability of qualifying assets at the Company. Interest is at
variable or fixed rates.
Through its membership, the Company has issued funding
agreements to the FHLB in exchange for cash advances. The Company
uses these funds in an investment spread strategy, consistent with
its other investment spread business. As such, the Company applies
SSAP No. 52, Deposit-Type Contracts, accounting treatment to these
funds, consistent with its other deposit-type contracts. It is not
part of the Company's general strategy to utilize funds for
operations, and any funds obtained from the FHLB for use in general
operations would be accounted for consistent with SSAP No. 15, Debt
and Holding Company Obligations, as borrowed money. There was no
debt outstanding with the FHLB as of March 31, 2020 and December
31, 2019.
2. FHLB Capital Stocka. Aggregate Totals
1. Current Year1
Total2+3
2GeneralAccount
3SeparateAccount
(a) Membership Stock - Class A * $500,000 $500,000 $0(b)
Membership Stock - Class B * 4,090,000 4,090,000 0(c) Activity
Stock 0 0(d) Excess Stock 978,100 978,100 0(e) Aggregate Total
$5,568,100 $5,568,100 $0(f) Actual or Estimated Borrowing
Capacity as Determined by theInsurer $1,268,000,000 XXX XXX
2. Prior Year1
Total2+3
2GeneralAccount
3SeparateAccount
(a) Membership Stock - Class A * $500,000 $500,000 $0(b)
Membership Stock - Class B * 4,090,000 4,090,000 0(c) Activity
Stock 0 0 0(d) Excess Stock 149,500 149,500 0(e) Aggregate Total
$4,739,500 $4,739,500 $0(f) Actual or Estimated Borrowing
Capacity as Determined by theInsurer $1,189,000,000 XXX XXX
* Required stock
b. Membership Stock (Class A and B) Eligible and Not Eligible
for Redemption
Membership StockCurrent Year
Total
Not Eligiblefor
RedemptionLess Than 6
Months
6 Months toLess Than 1
Year1 to Less Than
3 Years 3 to 5 Years1. Class A $500,000 $500,000 $0 $0 $0 $02.
Class B 4,090,000 4,090,000 0 0 0 0
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.10
3. Collateral Pledged to FHLB
a. Amount Pledged During Reporting Period
1Fair Value
2Carrying Value
3Aggregate Total
Borrowing
1. Current Year Total General and SeparateAccounts Total
Collateral Pledged(Lines 2 +3) $195,117,008 $192,006,482
$102,000,000
2. Current Year General Account TotalCollateral Pledged
195,117,008 192,006,482 102,000,000
3. Current Year Separate Account TotalCollateral Pledged 0 0
0
4. Prior Year-End Total General andSeparate Accounts Total
CollateralPledged 277,074,707 264,279,727 102,000,000
b. Maximum Amount Pledged During Reporting Period
1Fair Value
2Carrying Value
3Amount
Borrowed at Timeof Maximum
Collateral1. Current Year Total General and Separate
Accounts Maximum Collateral Pledged(Lines 2 +3) $264,026,630
$264,026,630 $102,000,000
2. Current Year General AccountMaximum Collateral Pledged
264,026,630 264,026,630 102,000,000
3. Current Year Separate AccountMaximum Collateral Pledged 0 0
0
4. Prior Year-End Total General andSeparate Accounts Maximum
CollateralPledged 388,756,147 388,756,147 102,000,000
4. Borrowing from FHLB
a. Amount as of Reporting Date
1Total 2+3
2General Account
3Separate Account
4Funding
Agreements Reserves
Established1. Current Year (a) Debt $0 $0 $0 XXX (b) Funding
Agreements 102,000,000 102,000,000 0 $102,000,000
(c) Other 0 0 0 XXX (d) Aggregate Total (a+b+c) $102,000,000
$102,000,000 $0 $102,000,000
2. Prior Year-end
(a) Debt $0 $0 $0 XXX (b) Funding Agreements 102,000,000
102,000,000 0 $102,000,000
(c) Other 0 0 0 XXX (d) Aggregate Total (a+b+c) $102,000,000
$102,000,000 $0 $102,000,000
b. Maximum Amount During Reporting Period
1Total2+3
2GeneralAccount
3SeparateAccount
1. Debt $20,000,000 $20,000,000 $02. Funding Agreements
102,000,000 102,000,000 03. Other 0 0 04. Aggregate Total (Lines
1+2+3) $122,000,000 $122,000,000 $0
c. The Company had no prepayment obligations from the FHLB.
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.11
12. RETIREMENT PLANS, DEFERRED COMPENSATION, POSTEMPLOYMENT
BENEFITS, COMPENSATED ABSENCES AND OTHER POSTRETIREMENT BENEFIT
PLANS
A. Defined Benefit Retirement Plan:
1-3. No significant change
4. Components of Net Periodic Benefits Pension Benefits
Postretirement BenefitsSpecial or Contractual
Benefits Per SSAP No. 11March 31,
2020December 31,
2019March 31,
2020December 31,
2019March 31,
2020December 31,
2019
a. Service Cost $1,321,399 $5,285,597 $0 $0 $0b. Interest Cost
745,114 2,980,454 81,500 326,000 0 0c. Expected Return on Plan
Assets 0 0 0 0d. Transition Asset or Obligation 0 0 0 0e. Gains and
Losses 265,151 1,060,604 42,750 171,000 0 0f. Prior Service Cost or
Credit 89,388 357,552 0 0 0g. Gain or Loss Recognized Due to a
Settlement or Curtailment 2,380,346 0 0 0h. Total Net Periodic
Benefit Cost $2,421,052 $12,064,553 $124,250 $497,000 $0 $0
5-18. No significant change
B-I. No significant change
13. CAPITAL AND SURPLUS, SHAREHOLDERS’ DIVIDEND RESTRICTIONS AND
QUASI-REORGANIZATIONS
1-10. No significant change
11. The Company issued the following surplus debentures or
similar obligations:
Date Issued Interest Rate
Par Value(Face Amount
of Notes) Carrying Value
of Notes
Principal And/Or Interest Paid
Current Year
Total PrincipalAnd/Or Interest
Paid
UnapprovedPrincipal And/
Or InterestDate of
Maturity12/30/1993 7.900% $133,549,000 $133,549,000 $0
$325,798,919 12/30/202306/15/2009 9.250% 384,555,000 384,555,000
35,571,338 1,538,795,646 06/15/203903/30/2010 6.000% 0 0 57,636,740
662,576,764 02/05/202001/22/2013 5.125% 410,490,000 406,665,938
10,518,806 258,751,435 01/25/204310/24/2017 4.300% 750,000,000
749,421,158 0 64,500,000 10/24/2067
Total $1,678,594,000 $1,674,191,096 $103,726,884 $2,850,422,764
XXX
On February 5, 2020, with the approval of the Director of the NE
DOI, the Company repaid the remaining $56 million of principal of
the 2010 Surplus Note.
12-13. No significant change
14. LIABILITIES, CONTINGENCIES AND ASSESSMENTS
No significant change
15. LEASES
No significant change
16. FINANCIAL INSTRUMENTS WITH OFF-BALANCE-SHEET RISK AND
FINANCIAL INSTRUMENTS WITH CONCENTRATIONS OF CREDIT RISK
1. The table below summarizes the face (notional) amount of the
Company’s financial instruments with off-balance-sheet risk.
Assets Liabilities
March 31, 2020 December 31, 2019 March 31, 2020 December 31,
2019a. Swaps $4,676,742,018 $5,169,393,053 $0 $0b. Futures
3,030,028,711 1,766,256,571 0 0c. Options 15,507,677,011
14,364,343,486 0 0d. Total $23,214,447,740 $21,299,993,110 $0
$0
See Schedule DB for additional detail.
2-4. No significant change
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.12
17. SALE, TRANSFER AND SERVICING OF FINANCIAL ASSETS AND
EXTINGUISHMENTS OF LIABILITIES
A. No significant change
B. Transfer and Servicing of Financial Assets
1. Loaned Securities:
The Company participates in a securities lending program whereby
securities are loaned to third parties for the purpose of enhancing
income on securities held through reinvestment of cash collateral
received upon lending. For securities lending transactions, the
Company requires a minimum initial collateral, usually in the form
of cash, equal to 102% of the fair value of the securities loaned.
The borrower of the loaned securities is permitted to sell or
repledge those securities. For securities lending transactions, the
carrying value of securities classified as bonds and on loan at
March 31, 2020 was $2.0 billion, with fair value of $1.9 billion.
The Company recorded cash collateral received under these
agreements of $2.0 billion and established a corresponding
liability for the same amount, which is included in payable for
securities lending on Page 3 – Liabilities, Surplus and Other
Funds. See Note 5.E. At March 31, 2020, there were no separate
accounts securities lending arrangements.
2-3. No significant change
4. The Company did not have securitized financial asset
transfers accounted for as a sale.
5-7. No significant change
C. Wash Sales:
1. In the course of the Company’s asset management activities,
securities are sold and reacquired within thirty days of the sale
date to enhance the Company’s yield on its investment
portfolio.
2. There were no securities with NAIC designation of 3 or below
or unrated sold during the three months ended March 31, 2020 and
reacquired within 30 days of the sale date.
18. GAIN OR LOSS TO THE REPORTING ENTITY FROM UNINSURED PLANS
AND THE UNINSURED PORTION OF PARTIALLY INSURED PLANS
No significant change
19. DIRECT PREMIUM WRITTEN/PRODUCED BY MANAGING GENERAL
AGENTS/THIRD-PARTY ADMINISTRATORS
Name and Address ofManaging General Agent orThird-Party
Administrator
FEINNumber
ExclusiveContract
Types ofBusinessWritten
Type ofAuthorityGranted*
Total DirectPremiums Written/
Produced ByM Financial Holdings1125 NW Couch Street, Suite
900Portland, OR 97209
93-1189872 No DirectPremiums P $27,476,197
Total XXX XXX XXX XXX $27,476,197*P - Premium Collection
20. FAIR VALUE MEASUREMENTS
A. The Company's financial assets and liabilities that are
carried at fair value have been classified, for disclosure
purposes, based on a hierarchy defined by SSAP No. 100R, Fair
Value. The determination of fair value requires the use of
observable market data when available. The hierarchy consists of
the following three levels that are prioritized based on observable
and unobservable inputs.
Level 1: Unadjusted quoted prices for identical instruments in
active markets. Level 1 financial instruments include securities
that are traded
in an active exchange market.
Level 2: Observable inputs other than Level 1 prices, such as
quoted prices for similar instruments in active markets; quoted
prices for identical or similar instruments in inactive markets;
and model-derived valuations for which all significant inputs are
observable market data.
Level 3: Valuations derived from valuation techniques in which
one or more significant inputs are not market observable.
Investments reported at Net Asset Value (NAV) are not captured
within the fair value hierarchy, but are separately identified in
the table below.
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.13
1. Fair Value Measurements of Financial Assets and Liabilities
Carried at Fair Value or NAV as of March 31, 2020:
Description for Each Class of Asset or Liability Level 1 Level 2
Level 3Net Asset
Value (NAV) Totala. Assets at Fair Value Bonds
Issuer Obligations $0 $8,350,000 $0 $0 $8,350,000LBASS 0 11,539
11,310,041 0 11,321,580
Total Bonds 0 8,361,539 11,310,041 0 19,671,580
Common StocksIndustrial and Miscellaneous 86,344 0 5,568,100 0
5,654,444Affiliates 200,663,663 (a) 0 0 0 200,663,663
Total Common Stocks 200,750,007 0 5,568,100 0 206,318,107
DerivativesForeign Currency and Interest Rate Swaps 0
530,371,532 0 0 530,371,532Equity Derivatives 326,760,800 0
320,912,290 0 647,673,090
Total Derivatives 326,760,800 530,371,532 320,912,290 0
1,178,044,622
Separate Account Assets (b) 47,740,631,986 0 0 416,009,183
48,156,641,169Total Assets at Fair Value/NAV $48,268,142,793
$538,733,071 $337,790,431 $416,009,183 $49,560,675,478
b. Liabilities at Fair Value Derivatives
Foreign Currency and Interest Rate Swaps $0 $78,805,915 $0 $0
$78,805,915Equity Derivatives 0 0 118,213,098 0 118,213,098
Total Derivatives 0 78,805,915 118,213,098 0 197,019,013Total
Liabilities at Fair Value $0 $78,805,915 $118,213,098 $0
$197,019,013
(a) Consists of mutual funds managed by affiliated entities.(b)
Separate account assets are measured at fair value. Investment
performance related to separate account assets is offset by
corresponding amounts credited to contract holders
whose liability is recorded in the separate account liabilities.
Separate account liabilities are measured to equal the fair value
of separate account assets. 2. Fair Value Measurements in Level 3
of the Fair Value Hierarchy:
Description
BeginningBalance atJanuary 1,
2020Transfers
Into Level 3Transfers Out
of Level 3
Total Gainsand (Losses)Included inNet Income
Total Gainsand (Losses)Included in
Surplus Purchases Issuances Sales Settlements
Ending Balanceat March 31,
2020
Bonds
LBASS $10,786,919 $478,112 (a) $0 $0 $45,010 $0 $0 $0 $0
$11,310,041
Common Stocks
Industrial andMiscellaneous 4,739,500 0 0 78,100 0 750,500 0 0 0
5,568,100
Derivatives, net 825,674,073 0 0 (431,356,814) (79,519,895)
62,057,850 0 0 (174,156,022) 202,699,192
Total $841,200,492 $478,112 $0 ($431,278,714) ($79,474,885)
$62,808,350 $0 $0 ($174,156,022) $219,577,333
(a) Transferred into Level 3 due to carrying value adjustments
down to fair value.
3. Transfers in and/or out are recognized at the end of each
quarter.
4. The fair values of bonds, preferred stocks and common stocks
are determined by management after considering external pricing
sources and internal valuation techniques. For securities with
sufficient trading volume, prices are obtained from third-party
pricing services. For securities that are traded infrequently, fair
values are determined after evaluating prices obtained from
third-party pricing services and independent brokers, or are valued
internally using various valuation techniques.
The Company's management analyzes and evaluates prices received
from independent third parties and determines whether they are
reasonable estimates of fair value. Management's analysis may
include, but is not limited to, review of third-party pricing
methodologies and inputs, analysis of recent trades, comparison to
prices received from other third parties, and development of
internal models utilizing observable market data of comparable
securities. The Company assesses the reasonableness of valuations
received from independent brokers by considering current market
dynamics and current pricing for similar securities.
For prices received from independent pricing services, the
Company applies a formal process to challenge any prices received
that are not considered representative of fair value. If prices
received from independent pricing services are not considered
reflective of market activity or representative of fair value,
independent non-binding broker quotations are obtained, or an
internally developed valuation is prepared. Upon evaluation, the
Company determines which source represents the best estimate of
fair value. Overrides of third-party prices to internally developed
valuations of fair value did not produce material differences in
the fair values for the majority of the portfolio; accordingly,
overrides were not material. In the absence of such market
observable activity, management’s best estimate is used.
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.14
Fair values determined by internally derived valuation tools use
market-observable data if available. Generally, this includes using
an actively traded comparable security as a benchmark for pricing.
These internal valuation methods primarily represent discounted
cash flow models that incorporate significant assumptive inputs
such as spreads, discount rates, default rates, severity, and
prepayment speeds. These inputs are analyzed by the Company’s
portfolio managers and analysts, investment accountants and risk
managers. Internally-developed estimates may also use unobservable
data, which reflect the Company’s own assumptions about the inputs
market participants would use.
Most securities priced by a major independent third-party
service have been classified as Level 2, as management has verified
that the significant inputs used in determining their fair values
are market observable and appropriate. Externally priced securities
for which fair value measurement inputs are not sufficiently
transparent, such as securities valued based on broker quotations,
have been classified as Level 3. Internally valued securities,
including adjusted prices received from independent third parties,
where significant management assumptions have been utilized in
determining fair value, have been classified as Level 3. Securities
categorized as Level 1 consist primarily of investments in mutual
funds.
The Company applies controls over the valuation process. Prices
are reviewed and approved by the Company’s professional credit
analysts that have industry expertise and considerable knowledge of
the issuers. Management performs validation checks to determine the
completeness and reasonableness of the pricing information, which
include, but are not limited to, changes from identified pricing
sources, significant or unusual price fluctuations above
predetermined tolerance levels from the prior period, and
back-testing of fair values against prices of actual trades. A
group comprised of the Company’s investment accountants, portfolio
managers and analysts and risk managers meet to discuss any unusual
items above the tolerance levels that may have been identified in
the pricing review process. These items are investigated, further
analysis is performed and resolutions are appropriately
documented.
Derivative instruments are reported at fair value using pricing
valuation models which utilize market data inputs or independent
broker quotations or exchange prices for exchange-traded futures.
The Company calculates the fair value of derivatives using market
standard valuation methodologies for foreign currency and interest
rate swaps and equity options. Internal models are used to value
equity total return swaps. The derivatives are valued using
mid-market inputs that are predominantly observable in the market.
Inputs include, but are not limited to, interest swap rates,
foreign currency forward and spot rates, credit spreads and
correlations, interest volatility, equity volatility and equity
index levels. On a monthly basis, the Company performs an analysis
of derivative valuations which includes both quantitative and
qualitative analyses. Examples of procedures performed include, but
are not limited to, review of pricing statistics and trends,
analysis of the impacts of changes in the market environment and
review of changes in the market value for each derivative by both
risk managers and investment accountants. Internally calculated
fair values are reviewed and compared to external broker fair
values for reasonableness.
Derivative instruments classified as Level 1 are
exchange-traded. Derivative instruments classified as Level 2
primarily include foreign currency and interest rate swaps. The
derivative valuations are determined using pricing models with
inputs that are observable in the market or can be derived
principally from or corroborated by observable market data,
primarily interest swap rates, interest rate volatility and foreign
currency forward and spot rates.
Derivative instruments classified as Level 3 include complex
derivatives, such as equity options and total return swaps. These
derivatives are valued using pricing models which utilize both
observable and unobservable inputs, primarily interest rate
volatility, equity volatility, equity index levels and, to a lesser
extent, broker quotations. A derivative instrument containing Level
2 inputs would be classified as a Level 3 financial instrument in
its entirety if it has at least one significant Level 3 input.
The fair value of separate account assets is based on the fair
value or NAV of the underlying assets. Separate account assets are
primarily invested in mutual funds but also have investments in
hedge funds.
Level 1 separate account assets include mutual funds that are
valued based on reported net asset values provided by fund managers
daily and can be redeemed without restriction. Management performs
validation checks to determine the reasonableness of the pricing
information, which include, but are not limited to, price
fluctuations above predetermined thresholds from the prior day and
validation against similar funds or indices. Variances are
investigated, further analysis is performed and resolutions are
appropriately documented.
NAV assets include separate account assets described in Note E.
below.
B. Disclosure of Fair Value of Financial Instruments:
The following methods and assumptions were used to estimate the
fair value of these financial instruments as of March 31, 2020:
Mortgage Loans: The fair value of the mortgage loan portfolio is
determined by discounting the estimated future cash flows, using
current rates that are applicable to similar yield, credit quality,
property type and average maturity of the composite portfolio.
Cash, Cash Equivalents and Short-Term Investments (including
Securities Lending Reinvested Collateral Assets): For cash and cash
equivalents with maturities of three months or less from date of
purchase, their fair values approximate their book/adjusted
carrying values due to their short maturities. For short-term
investments with maturities of one year or less from date of
purchase, excluding cash equivalents and money market mutual funds,
their fair values are determined using similar valuation techniques
as described above for bonds. Cash equivalents that are money
market mutual funds have fair values that approximate their
book/adjusted carrying values due to the short maturities of the
underlying investments of the funds. Securities lending reinvested
collateral assets that are primarily reverse purchase agreements
have fair values that approximate their book/adjusted carrying
values due to their short maturities.
Contract Loans: The admitted value of contract loans is a
reasonable estimate of their fair value because interest rates are
generally variable and based on current market rates.
Other Invested Assets: Other invested assets consist of surplus
note investments held from other insurance providers, WCFIs that
are NAIC rated 1 or 2 and tax credit investments. The fair values
of the surplus note investments are priced by an independent
pricing service as described for bonds above. The WCFIs are held at
accreted book value which approximates fair value due to the
short-term nature of the investment.
Liability for Deposit-Type Contracts: The primary methods used
to estimate the fair value of liability for deposit-type contracts
are based on the rates currently offered for deposits of similar
remaining maturities, or discounting estimated future cash flows
using the current average mid-market rate for illiquid A rated
insurance company debt or current market risk free interest
rates.
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.15
Borrowings: The admitted value of the commercial paper debt is a
reasonable estimate of the fair value due to the short-term nature
of the debt as well as interest rates are variable and based on
current market conditions. The secured borrowing fair value is
determined by discounting estimated future cash flows, using
current rates that are applicable to similar quality, collateral
type and maturity.
Separate Account Liability for Deposit-Type Contracts: The
statement value of separate account liability for deposit-type
contracts is reported under separate account liabilities and is a
reasonable estimate of their fair value because the contractual
interest rates are variable and based on current market rates.
C. Fair Value by Financial Instrument Type:
March 31, 2020
Type of Financial Instrument (1)Aggregate Fair
Value Admitted Value Level 1 Level 2 Level 3Net Asset
Value (NAV)
NotPracticable(Carrying
Value)Assets:Bonds $56,457,259,720 $55,254,673,649 $0
$53,762,395,853 $2,694,863,867 $0 $0Preferred Stocks 7,883,774
7,531,819 0 7,883,774 0 0 0Common Stocks (2) 206,318,107
206,318,107 200,750,007 0 5,568,100 0 0Mortgage Loans
13,882,802,917 14,068,049,676 0 0 13,882,802,917 0 0Cash, Cash
Equivalents and Short-TermInvestments 1,856,469,583 1,856,470,826
900,732,992 955,736,591 0 0 0Contract Loans 8,157,614,691
8,157,614,691 0 0 8,157,614,691 0 0Derivatives, net 981,025,609
981,025,609 326,760,800 451,565,617 202,699,192 0 0Securities
Lending Reinvested CollateralAssets (3) 2,038,636,735 2,038,636,735
0 2,038,636,735 0 0 0Other Invested Assets (2) 377,264,949
365,234,377 0 367,864,949 9,400,000 0 0Separate Account Assets
48,156,641,169 48,156,641,169 47,740,631,986 0 0 416,009,183 0
Liabilities:Liability for Deposit-Type Contracts (4)
5,055,411,005 4,187,300,694 0 0 5,055,411,005 0 0Borrowings
49,447,143 49,580,697 0 0 49,447,143 0 0Separate Account Liability
for Deposit-Type Contracts 3,368,237 3,368,237 0 0 3,368,237 0
0
December 31, 2019
Type of Financial Instrument (1)Aggregate Fair
Value Admitted Value Level 1 Level 2 Level 3Net Asset
Value (NAV)
NotPracticable(Carrying
Value)Assets:Bonds $57,097,604,028 $53,042,350,247 $0
$54,077,990,885 $3,019,613,143 $0 $0Preferred Stocks 11,524,072
10,731,507 0 11,524,072 0 0 0Common Stocks (2) 249,090,879
249,090,879 244,351,379 0 4,739,500 0 0Mortgage Loans
14,625,781,749 13,684,963,866 0 0 14,625,781,749 0 0Cash, Cash
Equivalents and Short-TermInvestments 3,710,486,729 3,710,559,929
1,219,269,023 2,491,217,706 0 0 0Contract Loans 7,940,193,877
7,940,193,877 0 0 7,940,193,877 0 0Derivatives, net 993,603,388
993,603,388 72,021,600 95,907,715 825,674,073 0 0Securities Lending
Reinvested CollateralAssets (3) 2,130,824,920 2,130,824,920 0
2,130,824,920 0 0 0Other Invested Assets (2) 469,623,419
449,053,342 0 460,323,419 9,300,000 0 0Separate Account Assets
57,266,846,432 57,266,846,432 56,864,801,370 0 0 402,045,062 0
Liabilities:Liability for Deposit-Type Contracts (4)
4,444,034,343 3,993,894,363 0 0 4,444,034,343 0 0Borrowings
54,095,525 49,826,132 0 0 54,095,525 0 0Separate Account Liability
for Deposit-Type Contracts 4,247,830 4,247,830 0 0 4,247,830 0
0
(1) The tables above exclude the following financial
instruments: investment income due and accrued and derivatives
collateral receivable andpayable. The fair value of these financial
instruments, which are primarily classified as Level 2,
approximates carrying value as they are short–termin nature such
that there is minimal risk of material changes in fair value due to
changes in interest rates or counterparty credit(2) Excludes
investments accounted for under the equity method(3) Excludes
payable for securities lending as it equals the securities lending
reinvested collateral(4) Excludes deposit liabilities with no
defined or contractual maturities
D. The Company had no investments where it was not practicable
to estimate fair value.
E. Investments Measured Using the NAV Practical Expedient:
Separate account assets include hedge funds where the fair value
is based on the net asset value obtained from the fund managers.
Investment strategies related to this asset class includes
multi-strategy primarily invested in the U.S. and international
equity, fixed income, loans, real estate, derivatives, privately
held companies and private partnerships. The redemption frequency
can be monthly, quarterly, semi-annually and annually. The
remaining lockup period ranges from zero to four years as of March
31, 2020. There are no unfunded commitments as of March 31,
2020.
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.16
21. OTHER ITEMS
A-B. No significant change
C. Other Disclosures
1. Ceded Affiliated Reinsurance
Pacific Life Reinsurance (Barbados) Limited (PLRB), a direct,
wholly owned subsidiary of Pacific LifeCorp, was a Barbados-based
life reinsurance company. Effective March 31, 2020, PLRB changed
its name to Pacific Life Re Global Limited (PLRG) and was
redomiciled to and licensed as a life reinsurance company in
Bermuda. PLRG assumes U.S. life retrocession business through the
Company, as well as other non-U.S. life retrocession business. PLRG
also became a direct, wholly-owned subsidiary of Pacific Life Re
Holding LLC, which is a direct, wholly-owned subsidiary of Pacific
Life Re Holding LLC, which is a direct, wholly-owned subsidiary of
Pacific LifeCorp, on March 31, 2020.
The Company has reinsurance agreements with PLRG. The underlying
reinsurance is comprised of coinsurance and Yearly Renewable Term
(YRT) treaties. The Company retroceded statutory reserves for the
majority of the underlying YRT treaties on a 100% coinsurance with
funds withheld basis to PLRG. The statutory accounting reserve
credit is supported by a $355 million Letter of credit (LOC) issued
to PLRG by a highly rated third-party bank for the benefit of
Pacific Life, which expires August 2021. In connection with the
LOC, Pacific LifeCorp has provided a guarantee to the bank for
certain obligations under the LOC agreement. In addition, Pacific
LifeCorp entered into a capital maintenance agreement with
PLRG.
2. No significant change
3. Other disclosures:
The Company has ceded reinsurance contracts in place with a
reinsurer whose financial stability has deteriorated. In March
2019, the reinsurer's domiciliary state regulator issued a
rehabilitation and injunction order, in which the regulator shall
conduct and continue business of the reinsurer. As of March 31,
2020, the Company does not expect the financial deterioration of
the reinsurer to have a material adverse effect on the Company's
financial statements.
As of March 31, 2020, the Company had $391 million of
outstanding contractual obligations to acquire private placement
securities and outstanding mortgage loan commitments to fund $1,409
million primarily in construction loan advances.
D-I. No significant change
22. EVENTS SUBSEQUENT
The Company has evaluated events subsequent to March 31, 2020
and through May 15, 2020, the date this Quarterly Statement was
filed and has concluded that no events have occurred that required
adjustments to this Quarterly Statement. The Company has not
evaluated subsequent events after the filing date.
The Company is working with borrowers who are experiencing
financial difficulty as a direct result of the COVID-19 pandemic.
When necessary, the Company is providing temporary (six months or
less) loan modifications to assist borrowers with their current
circumstance. On April 7, 2020 a group of banking agencies issued
an Interagency Statement that offers practical expedients for
evaluating whether loan modifications that occur in response to
COVID-19 are troubled debt restructures (TDR) consistent with the
Coronavirus Aid, Relief and Economic Security Act (the CARES Act).
The Company's loan modifications fall within the guidance of the
April 7, 2020 Interagency Statement, as adopted by the NAIC under
INT 20-03, and do not qualify as TDRs.
Economic and capital market uncertainties have arisen as a
result of the spread of COVID-19. The impact of COVID-19 on the
Company is constantly evolving and its future effects are uncertain
and cannot be reasonably estimated as of the date this report was
filed. Interest rates and equity market levels have had the most
significant effect on the Company's financial statements. COVID-19
related claims have been minor through May 15, 2020. The Company
continues to actively monitor direct and indirect impacts of the
pandemic on its financial statements, especially in relation to
claims and the investments portfolio.
23. REINSURANCE
No significant change
24. RETROSPECTIVELY RATED CONTRACTS & CONTRACTS SUBJECT TO
REDETERMINATION
A-D. No significant change
E. The Company does not write any accident and health insurance
premium that is subject to the Affordable Care Act risk-sharing
provisions.
25. CHANGE IN INCURRED LOSSES AND LOSS ADJUSTMENT EXPENSES
A. As of March 31, 2020 and December 31, 2019, there were $18
million in aggregate reserves for accident and health
contracts.
B. There were no significant changes in methodology or
assumptions of the reserves.
26. INTERCOMPANY POOLING ARRANGEMENTS
No significant change
27. STRUCTURED SETTLEMENTS
No significant change
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.17
28. HEALTH CARE RECEIVABLES
No significant change
29. PARTICIPATING POLICIES
No significant change
30. PREMIUM DEFICIENCY RESERVES
No significant change
31. RESERVES FOR LIFE CONTRACTS AND ANNUITY CONTRACTS
No significant change
-
STATEMENT AS OF MARCH 31, 2020 OF THE PACIFIC LIFE INSURANCE
COMPANY
NOTES TO FINANCIAL STATEMENTS
7.18
32. ANALYSIS OF ANNUITY ACTUARIAL RESERVES AND DEPOSIT TYPE
CONTRACT LIABILITIES BY WITHDRAWAL CHARACTERISTICS
A. INDIVIDUAL ANNUITIES
General Account
Separate Account
with Guarantees
Separate Account
Nonguaranteed Total% ofTotal
(1). Subject to Discretionary Withdrawal:
a. With Market Value Adjustment $14,456,646,144 $0 $0
$14,456,646,144 21%b. At Book Value Less Current Surrender Charge
of 5%
or More * 2,405,045,324 0 0 2,405,045,324 4%c. At Fair Value 0 0
40,051,280,395 40,051,280,395 57%d. Total with Market Value
Adjustment or at Fair Value
(Total of a Through c) 16,861,691,468 0 40,051,280,395
56,912,971,863 82%e. At Book Value without Adjustment (Minimal or
No
Charge or Adjustment) 5,821,224,046 0 0 5,821,224,046 8%(2). Not
Subject to Discretionary Withdrawal 7,324,824,036 0 1,834,846
7,326,658,882 10